ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE- aspirin and extended-release dipyridamole capsule アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

aspirin and extended-release dipyridamole- aspirin and extended-release dipyridamole capsule

american health packaging - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin, usp is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis and nasal polyps. aspirin, usp may cause severe urticaria, angioedema or bronchospasm. do not use aspirin, usp in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects, pregnancy category d. [see warnings and precautions (5.4)]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pr

Aspirin 300mg gastro-resistant tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspirin 300mg gastro-resistant tablets

alliance healthcare (distribution) ltd - aspirin - gastro-resistant tablet - 300mg